Novacyt S.A.
EPA:ALNOV.PA
0.776 (EUR) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 11.579 | 21.04 | 95.78 | 277.204 | 11.176 | 12.369 | 13.275 | 9.441 | 6.562 | 3.539 | 1.006 | 0.902 | 0.763 |
| Cost of Revenue
| 7.849 | 15.294 | 66.102 | 66.077 | 4.023 | 4.612 | 5.353 | 4.259 | 3.407 | 3.356 | 1.161 | 0.737 | 0.707 |
| Gross Profit
| 3.73 | 5.746 | 29.678 | 211.127 | 7.152 | 7.757 | 7.922 | 5.183 | 3.155 | 0.183 | -0.155 | 0.165 | 0.055 |
| Gross Profit Ratio
| 0.322 | 0.273 | 0.31 | 0.762 | 0.64 | 0.627 | 0.597 | 0.549 | 0.481 | 0.052 | -0.154 | 0.183 | 0.073 |
| Reseach & Development Expenses
| 3.228 | 5.047 | 4.815 | 1.63 | 0.385 | 0.366 | 0.727 | 0.677 | 0.434 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 4.884 | 4.856 | 6.81 | 4.107 | 5.524 | 5.516 | 6.315 | 1.754 | 3.531 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0.994 | 4.826 | 7.025 | 4.492 | 2.307 | 2.212 | 2.884 | 0.936 | 1.686 | 0 | 0 | 0 | 0 |
| SG&A
| 5.878 | 9.682 | 13.835 | 8.599 | 7.831 | 7.728 | 9.2 | 2.69 | 5.217 | 0 | 0 | 0 | 0 |
| Other Expenses
| 0 | 7.619 | 12.395 | 25.975 | 0.077 | 5.324 | 5.632 | -0.107 | -0.105 | 1.664 | 0.919 | 0.633 | 0.628 |
| Operating Expenses
| 21.892 | 22.348 | 31.045 | 36.204 | 8.293 | 8.327 | 11.536 | 7.729 | 5.547 | 1.664 | 0.919 | 0.633 | 0.628 |
| Operating Income
| -29.516 | -16.602 | -1.367 | 167.441 | -1.141 | -1.249 | -3.614 | -3.803 | -9.73 | -1.481 | -1.074 | -0.468 | -0.572 |
| Operating Income Ratio
| -2.549 | -0.789 | -0.014 | 0.604 | -0.102 | -0.101 | -0.272 | -0.403 | -1.483 | -0.419 | -1.068 | -0.519 | -0.75 |
| Total Other Income Expenses Net
| 0.948 | -3.451 | -8.462 | -2.27 | -2.2 | -1.364 | -2.946 | -2.07 | -7.871 | -0.155 | -0.001 | -0.085 | -0.099 |
| Income Before Tax
| -28.568 | -20.053 | -9.829 | 165.171 | -3.34 | -1.875 | -4.833 | -4.866 | -10.263 | -1.636 | -1.075 | -0.554 | -0.671 |
| Income Before Tax Ratio
| -2.467 | -0.953 | -0.103 | 0.596 | -0.299 | -0.152 | -0.364 | -0.515 | -1.564 | -0.462 | -1.068 | -0.614 | -0.88 |
| Income Tax Expense
| -0.768 | 2.148 | -0.101 | 32.748 | -0.007 | 0.029 | -0.002 | 0.002 | 0.001 | 0.481 | -0.194 | -0.098 | -0.099 |
| Net Income
| -28.292 | -22.201 | -9.728 | 132.423 | -3.334 | -4.271 | -4.831 | -4.867 | -10.264 | -2.892 | -0.832 | -0.455 | -0.572 |
| Net Income Ratio
| -2.443 | -1.055 | -0.102 | 0.478 | -0.298 | -0.345 | -0.364 | -0.516 | -1.564 | -0.817 | -0.827 | -0.505 | -0.749 |
| EPS
| -0.4 | -0.31 | -0.14 | 1.94 | -0.073 | -0.11 | -0.21 | -0.4 | -1.51 | -0.65 | -0.28 | -0.17 | -0.21 |
| EPS Diluted
| -0.4 | -0.31 | -0.14 | 1.94 | -0.073 | -0.11 | -0.21 | -0.4 | -1.51 | -0.65 | -0.28 | -0.17 | -0.21 |
| EBITDA
| -12.734 | -10.066 | -1.221 | 169.569 | -1.419 | -0.691 | -3.213 | -2.225 | -2.019 | -0.678 | -0.707 | -0.292 | -0.439 |
| EBITDA Ratio
| -1.1 | -0.478 | -0.013 | 0.612 | -0.127 | -0.056 | -0.242 | -0.236 | -0.308 | -0.192 | -0.703 | -0.324 | -0.576 |